cisatracurium has been researched along with Critical Illness in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilokpattanamongkol, P; Nosoongnoen, W; Panusitthikorn, P; Suthisisang, C; Tangsujaritvijit, V | 1 |
| Azouzi, A; Boussarsar, M; Fraj, N; Meddeb, K; Romdhani, S; Saad, HB | 1 |
| Szakmany, T; Woodhouse, T | 1 |
| Meeder, AM; Rozendaal, A; van der Steen, MS; van Zanten, AR | 1 |
| Kruger, PS; Liu, X; Roberts, MS; Weiss, M | 1 |
| Bonmarchand, G; Duflo, A; Girault, C; Hamelin, K; Richard, JC; Tamion, F | 1 |
| De Laet, I; De Waele, JJ; Hoste, E; Verholen, E | 1 |
| Beale, RJ; Bion, JF; Boyd, AH; Eastwood, NB; Elliot, JM; Grounds, RM; Harper, NJ; Hunter, JM; Newman, PJ; Pearson, AJ; Pollard, BJ; Quinn, AC; Sutjarittam, M | 1 |
1 review(s) available for cisatracurium and Critical Illness
| Article | Year |
|---|---|
Use of cisatracurium in critical care: a review of the literature.
Topics: Atracurium; Critical Care; Critical Illness; Humans; Neuromuscular Nondepolarizing Agents | 2015 |
3 trial(s) available for cisatracurium and Critical Illness
| Article | Year |
|---|---|
Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
Topics: Acute Disease; Adult; Atracurium; Critical Illness; Cross-Over Studies; Double-Blind Method; Drugs, Generic; Female; Humans; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Monitoring; Respiration, Artificial; Respiratory Insufficiency | 2020 |
Gastric emptying in mechanically ventilated critically ill patients: effect of neuromuscular blocking agent.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Atracurium; Conscious Sedation; Critical Illness; Female; Gastric Emptying; Humans; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies; Respiration, Artificial; Time Factors | 2003 |
A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Topics: APACHE; Atracurium; Critical Care; Critical Illness; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Linear Models; Male; Middle Aged; Neuromuscular Blocking Agents; Respiration, Artificial | 1997 |
4 other study(ies) available for cisatracurium and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics studies of a loading dose of cisatracurium in critically ill patients with respiratory failure.
Topics: Adult; Aged; Aged, 80 and over; Atracurium; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency | 2022 |
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
Topics: Aged; Atracurium; Critical Illness; Female; Humans; Infusions, Intravenous; Male; Monitoring, Physiologic; Neuromuscular Blocking Agents; Phlebitis | 2016 |
The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis.
Topics: Adult; Aged; Atracurium; Critical Illness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Models, Biological; Neuromuscular Blocking Agents; Sepsis; Severity of Illness Index; Time Factors | 2012 |
The effect of neuromuscular blockers in patients with intra-abdominal hypertension.
Topics: Abdomen; Adult; Aged; Atracurium; Critical Illness; Female; Humans; Hypertension; Intensive Care Units; Male; Middle Aged; Neuromuscular Blocking Agents; Prospective Studies | 2007 |